Pharmacotherapy for Type 2 Diabetes Based on the 2018 Diabetes Canada Guidelines – Mainpro+

Upon successful completion of this continuing education activity, the clinician will be better able to:

1. Describe the importance of a multifactorial approach to pharmacotherapy in the management of type 2 diabetes, including glycemic control, weight reduction, increasing physical activity, improving dyslipidemia and CV risk reduction
2. Understand the importance of weight on the management type 2 diabetes and antihyperglycemic selection
3. Facilitate clinical decision making for selecting the appropriate class of drug for the individual patient
4. Differentiate between GLP-1 RAs and SGLT2 inhibitors in vascular risk reduction
5. Review the impact of frailty and renal function on the management of type 2 diabetes